Description

Liraglutide, commonly referred to as a glucagon-like peptide-1 (GLP-1) receptor agonist studied in metabolic research, is investigated in laboratory environments for its involvement in glucose regulation pathways, endocrine signaling mechanisms, and metabolic related biological processes. Researchers explore it in experimental models related to insulin signaling, appetite associated pathways, and energy balance regulation.

This product is supplied strictly for laboratory and research use only and is not intended for human or veterinary administration.

Key Research Areas:
• Glucose regulation and metabolic signaling models
• Endocrine and insulin pathway research
• Appetite and satiety related signaling studies
• Energy balance and metabolic biology research

Quality Commitment:
Each vial is produced to high analytical standards and supported by third party testing for identity and purity to ensure reliability in experimental environments.